Revlimid-$64,000/year, 3 Black Boxes, DVT's

[Anonymous]

Revlimid pre- launch hype and then the reality of the PI.

The $64,000/year drug that can't be used on mod-severe renal patients

DVT's (PE's) and body comdoms- nice

[Anonymous]

Sounds like REV must be eating your lunch, you sell Vidaza or Dacogen you puss bucket?

[Anonymous]

Dacogen making a dent?

[Anonymous]

Dacogen making a dent?

It is doing well. MGI has reported solid sales.

[Anonymous]

Dacogen making a dent?

In a nutshell - Yes! Unfortunately, it is only a matter of time before one fails and another is used. The great thing is that both are now available and Vidaza is all but cooked.